Engineers Gate Manager LP Magenta Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.36 - $1.59 $12,272 - $54,203	34,090 New	34,090 $13,000
Q1 2022 May 16, 2022	SELL	$2.55 - $5.23 $38,665 - $79,302	-15,163 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.43 - $8.33 $22,429 - $42,174	5,063 Added 50.13%	15,163 $67,000
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $61,307 - $99,889	10,100 New	10,100 $74,000
Q4 2020 Feb 16, 2021	SELL	$6.1 - $7.94 $73,810 - $96,074	-12,100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$6.52 - $8.94 $78,892 - $108,174	12,100 New	12,100 $82,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.